LFG
PRAX icon

Larson Financial Group’s Praxis Precision Medicines PRAX Stock Holding History

Larson Financial Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.8K Sell
68
-30
-31% -$9.5K ﹤0.01% 1940
2026
Q1 		$31.6K Buy
98
+8
+9% +$2.48K ﹤0.01% 1599
2025
Q4 		$26.5K Buy
90
+19
+27% +$3.54K ﹤0.01% 1556
2025
Q3 		$3.76K Buy
71
+33
+87% +$1.6K ﹤0.01% 2460
2025
Q2 		$1.6K Buy
+38
New +$1.45K ﹤0.01% 2495

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Larson Financial Group's PRAX Position: Q2 2026 in Review

Larson Financial Group reduced its Praxis Precision Medicines (PRAX) stake by 31% in Q2 2026, selling an estimated $9.5K and leaving 68 shares worth $22.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1940.

Larson Financial Group first reported a position in PRAX in Q2 2025 and has held it in 5 quarters since. The position peaked at $31.6K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Larson Financial Group held 68 shares of Praxis Precision Medicines worth $22.8K as of Q2 2026.
  • Larson Financial Group sold 30 Praxis Precision Medicines shares in Q2 2026, an estimated $9.5K.
  • Praxis Precision Medicines made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1940 holding.
  • Larson Financial Group first reported a position in Praxis Precision Medicines in Q2 2025 and has held it in 5 quarters since.
  • Larson Financial Group's Praxis Precision Medicines position peaked at $31.6K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.